Invention Grant
- Patent Title: Antibodies against factor XII and uses thereof
- Patent Title (中): 抗因子XII的抗体及其用途
-
Application No.: US14649972Application Date: 2013-12-06
-
Publication No.: US09574013B2Publication Date: 2017-02-21
- Inventor: Andras Gruber , David Gailani , Philberta Leung , Anton Matafonov
- Applicant: VANDERBILT UNIVERSITY , ARONORA, INC. , OREGON HEALTH & SCIENCE UNIVERSITY
- Applicant Address: US TN Nashville US OR Portland US OR Portland
- Assignee: VANDERBILT UNIVERSITY,ARONORA, INC.,OREGON HEALTH & SCIENCE UNIVERSITY
- Current Assignee: VANDERBILT UNIVERSITY,ARONORA, INC.,OREGON HEALTH & SCIENCE UNIVERSITY
- Current Assignee Address: US TN Nashville US OR Portland US OR Portland
- Agency: Parker Highlander, PLLC
- International Application: PCT/US2013/073690 WO 20131206
- International Announcement: WO2014/089493 WO 20140612
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/36 ; C07K16/40 ; A61K39/00
Abstract:
Provided are antibodies that selectively bind to and inhibit activation of coagulation factor XII. Methods of treatment employing these antibodies are described herein.
Public/Granted literature
- US20150315292A1 ANTIBODIES AGAINST FACTOR XII AND USES THEREOF Public/Granted day:2015-11-05
Information query
